Mary A. Millner

FDA investigator

Appears on 9 documents from 2015 to 2024, mostly at sites in Tennessee. Most often cites corrective and preventive action (21 CFR 820.100).

9
Documents on file
6.4
Observations per 483
2015
First seen
2024
Most recent

What they cite most

From 51 observations

Activity by year

2015: 2, 2016: 2, 2017: 1, 2018: 1, 2019: 1, 2021: 1, 2024: 1

Where

Tennessee 7 · California 1 · Florida 1

Is Mary A. Millner coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Dexcom, IncNov 7, 2024 · San Diego, California
483 B. Braun US Pharmaceutical Manufacturing LLCNov 5, 2021 · Daytona Beach, Florida
483 Advanced Machine, IncMay 2, 2019 · Winchester, Tennessee
483 Diasol East, Inc.Aug 22, 2018 · Watertown, Tennessee
483 Diasol East, Inc.Mar 17, 2017 · Watertown, Tennessee
Amended 483 Customer Service Associates, LLCOct 21, 2016 · Winchester, Tennessee
483 Somnowell, IncMar 10, 2016 · Bellevue, Tennessee

About this profile

What does Mary A. Millner inspect?

Mary A. Millner appears on 9 documents on file covering 7 sites, mostly in Tennessee.

What do they cite most often?

21 CFR 820.100 (corrective and preventive action), followed by 21 CFR 820.30(c) and 21 CFR 211.42(b).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Mary A. Millner is dated Nov 7, 2024.